Severe psychiatric disorders in mid-life and risk of dementia in late-life (age 65-84 years): A population based case-control study

Current Alzheimer Research

Volumn 11, Issue 7, 2014, Pages 681-693

  Zilkens, Renate R ^a   Bruce, David G ^b   Duke, Janine ^c   Spilsbury, Katrina ^a   Semmens, James B ^a  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Alzheimer's disease; Anxiety disorder; Bipolar disorder; Case control studies; Dementia; Depression; Risk factors; Schizophrenia

Indexed keywords

AGED; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; AUSTRALIAN; BIPOLAR DEPRESSION; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE SEVERITY; DISEASES; FEMALE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; ONSET AGE; PERSONAL EXPERIENCE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SMOKING; ADULT; ALZHEIMER DISEASE; CASE CONTROL STUDY; DEATH; DYSTHYMIA; EPIDEMIOLOGY; HEALTH CARE FACILITY; HOSPITAL PATIENT; HYPERLIPIDEMIA; MAJOR DEPRESSION; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MEDICAL SPECIALIST; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; MULTIINFARCT DEMENTIA; OUTPATIENT; VERY ELDERLY; AGE; AGING; AUSTRALIA; MENTAL DISORDERS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; AUSTRALIA; CASE-CONTROL STUDIES; COHORT STUDIES; DEMENTIA; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MENTAL DISORDERS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84906903624     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205011666140812115004     Document Type: Article

References (67)

1. National Institute of Health. State-of-the-Science Conference statement: preventing Alzheimer's disease and cognitive decline April 26-28 2010 http://consensus.nih.gov/2010/alzstatement.htm Accessed May 2012.
2. Elmstahl S, Stenberg I, Annerstedt L, Ingvad B. Behavioral disturbances and pharmacological treatment of patients with dementia in family caregiving: a 2-year follow-up. Int Psychogeriatr 10: 239-52 (1998).
3. Jorm AF. History of depression as a risk factor for dementia: an updated review. Aust N Z J Psychiatry 35: 776-81 (2001).
4. Berger AK, Fratiglioni L, Forsell Y, Winblad B, Backman L. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 53: 1998-2002 (1999).
5. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63: 530-8 (2006).
6. Speck CE, Kukull WA, Brenner DE, Bowen JD, McCormick WC, Teri L, et al. History of depression as a risk factor for Alzheimer's disease. Epidemiology 6: 366-9 (1995).
7. Moffitt TE, Caspi A, Taylor A, Kokaua J, Milne BJ, Polanczyk G, et al. How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med 40: 899-909 (2010).
8. Palsson S, Aevarsson O, Skoog I. Depression, cerebral atrophy, cognitive performance and incidence of dementia. Population study of 85-year-olds. Br J Psychiatry 174: 249-53 (1999).
9. Geerlings MI, den Heijer T, Koudstaal PJ, Hofman A, Breteler MM. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease. Neurology 70: 1258-64 (2008).
10. Dotson VM, Beydoun MA, Zonderman AB. Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75: 27-34 (2010).
11. Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry 69: 493-8 (2012).
12. da Silva J, Goncalves-Pereira M, Xavier M, Mukaetova-Ladinska EB. Affective disorders and risk of developing dementia: systematic review. Br J Psychiatry 202: 177-86 (2013).
13. Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, et al. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol 60: 753-9 (2003).
14. Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS, Ballard DJ. Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 41: 1393-7 (1991).
15. Cooper B, Holmes C. Previous psychiatric history as a risk factor for late-life dementia: a population-based case-control study. Age Ageing 27: 181-8 (1998).
16. Kessing LV, Olsen EW, Mortensen PB, Andersen PK. Dementia in affective disorder: a case-register study. Acta Psychiatr Scand 100: 176-85 (1999).
17. Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord 73: 261-9 (2003).
18. Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J Neurol Neurosurg Psychiatry 75: 1662-6 (2004).
19. Shah JN, Qureshi SU, Jawaid A, Schulz PE. Is there evidence for late cognitive decline in chronic schizophrenia? Psychiatr Q 83: 127-44 (2012).
20. Korner A, Lopez AG, Lauritzen L, Andersen PK, Kessing LV. Late and very-late first-contact schizophrenia and the risk of dementia--a nationwide register based study. Int J Geriatr Psychiatry 24: 61-7 (2009).
21. Brodaty H, Sachdev P, Koschera A, Monk D, Cullen B. Long-term outcome of late-onset schizophrenia: 5-year follow-up study. Br J Psychiatry 183: 213-9 (2003).
22. Rabins PV, Lavrisha M. Long-term follow-up and phenomenologic differences distinguish among late-onset schizophrenia, late-life depression, and progressive dementia. Am J Geriatr Psychiatry 11: 589-94 (2003).
23. Palmer K, Berger AK, Monastero R, Winblad B, Backman L, Fratiglioni L. Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology 68: 1596-602 (2007).
24. Wilson RS, Barnes LL, Bennett DA, Li Y, Bienias JL, Mendes de Leon CF, et al. Proneness to psychological distress and risk of Alzheimer disease in a biracial community. Neurology 64: 380-2 (2005).
25. Gallacher J, Bayer A, Fish M, Pickering J, Pedro S, Dunstan F, et al. Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study. Psychosom Med 71: 659-66 (2009).
26. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65: 545-51 (2005).
27. Rusanen M, Kivipelto M, Quesenberry CP, Jr., Zhou J, Whitmer RA. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med 171: 333-9 (2011).
28. Fleminger S, Oliver DL, Lovestone S, Rabe-Hesketh S, Giora A. Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry 74: 857-62 (2003).
29. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64: 277-81 (2005).
30. Xu W, Qiu C, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midand late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 58: 71-7 (2009).
31. Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol 585: 97-108 (2008).
32. Bruce DG, Davis WA, Casey GP, Starkstein SE, Clarnette RM, Foster JK, et al. Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 51: 241-8 (2008).
33. Holman CD, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 23: 453-9 (1999).
34. Holman CD, Bass AJ, Rosman DL, Smith MB, Semmens JB, Glasson EJ, et al. A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage system. Aust Health Rev 32: 766-77 (2008).
35. Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, et al. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain133: 512-28 (2010).
36. Snowden JS, Stopford CL, Julien CL, Thompson JC, Davidson Y, Gibbons L, et al. Cognitive phenotypes in Alzheimer's disease and genetic risk. Cortex 43: 835-45 (2007).
37. Zilkens RR, Spilsbury K, Bruce DG, Semmens JB. Clinical epidemiology and in-patient hospital use in the last year of life (1990-2005) of 29,884 Western Australians with dementia. J Alzheimer Dis 17: 399-407 (2009).
38. Zilkens RR, Spilsbury K, Bruce DG, Semmens JB. Linkage of hospital and death records increased identification of dementia cases and death rate estimates. Neuroepidemiology 32: 61-9 (2009).
39. Australian Electoral Commmission (AEC). Elector count by division, age groups and gender for all States/Territories. 2011.
40. Thomas VS, Rockwood KJ. Alcohol abuse, cognitive impairment, and mortality among older people. J Am Geriatr Soc 49: 415-20 (2001).
41. Graban A, Bednarska-Makaruk M, Bochynska A, Lipczynska-Lojkowska W, Ryglewicz D, Wehr H. Vascular and biochemical risk factors of vascular dementia after lacunar strokes (S-VaD) and after multiinfarcts in strategic areas (M-VaD). J Neurol Sci 283: 116-8 (2009).
42. Honig LS, Tang MX, Albert S, Costa R, Luchsinger J, Manly J, et al. Stroke and the risk of Alzheimer disease. Arch Neurol 60: 1707-1712 (2003).
43. Schnaider Beeri M, Goldbourt U, Silverman JM, Noy S, Schmeidler J, Ravona-Springer R, et al. Diabetes mellitus in midlife and the risk of dementia three decades later Neurology; 63: 1902-7 (2004).
44. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5: 64-74 (2006).
45. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10: 819-28 (2011).
46. Allison PD. Logistic Regression Using the SAS System: Theory and Application. Cary, NC: SAS Institute Inc.; 1999.
47. Ritchie K, Carriere I, Ritchie CW, Berr C, Artero S, Ancelin ML. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. Br Med J 341 (2010).
48. Rugulies R. Depression as a predictor for coronary heart disease. a review and meta-analysis. Am J Prev Med 23: 51-61 (2002).
49. Jakobsen AH, Foldager L, Parker G, Munk-Jorgensen P. Quantifying links between acute myocardial infarction and depression, anxiety and schizophrenia using case register databases. J Affect Disord 109: 177-81 (2008).
50. Strine TW, Mokdad AH, Dube SR, Balluz LS, Gonzalez O, Berry JT, et al. The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults. Gen Hosp Psychiatry 230: 127-37 (2008).
51. Alexopoulos GS. Vascular disease, depression, and dementia. J Am Geriatr Soc 51(8): 1178-80 (2003).
52. Morgan VA, Waterreus A, Jablensky A, Mackinnon A, McGrath JJ, Carr V, et al. People living with psychotic illness in 2010: the second Australian national survey of psychosis. Aust N Z J Psychiatry 46(8): 735-52 (2012).
53. Goldberg D, Fawcett J. The importance of anxiety in both major depression and bipolar disorder. Depress Anxiety 29(6): 471-8 (2012).
54. Masouy A, Chopard G, Vandel P, Magnin E, Rumbach L, Sechter D, et al. Bipolar disorder and dementia: where is the link? Psychogeriatrics 11(1): 60-7 (2011).
55. Prestia A, Boccardi M, Galluzzi S, Cavedo E, Adorni A, Soricelli A, et al. Hippocampal and amygdalar volume changes in elderly patients with Alzheimer's disease and schizophrenia. Psychiatry Res 192(2): 77-83 (2011).
56. Religa D, Laudon H, Styczynska M, Winblad B, Naslund J, Haroutunian V. Amyloid beta pathology in Alzheimer's disease and schizophrenia. Am J Psychiatry 160(5): 867-72 (2003).
57. Tyas SL. Alcohol use and the risk of developing Alzheimer's disease. Alcohol Res Health 25(4): 299-306 (2001).
58. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuropsychopharmacol Biol Psychiatry 35(3): 664-75 (2011).
59. Koyama A, O'Brien J, Weuve J, Blacker D, Metti AL, Yaffe K. The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. J Gerontol A Biol Sci Med Sci 68(4): 433-40 (2013).
60. Rasgon N, Jarvik L. Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. J Gerontol A Biol Sci Med Sci 59(2): 178-183; discussion 84-92 (2004).
61. Rasgon NL, Kenna HA, Wroolie TE, Kelley R, Silverman D, Brooks J, et al. Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. Neurobiol Aging 32(11): 1942-8 (2011).
62. Britt H, Miller GC, Charles J, Henderson J, Bayram C, Pan Y, et al. General practice activity in Australia 2008-2009.The University of Sydney and the Australian Institute of Health and Welfare. Cat no GEP 25 (2009).
63. Bauer M, Pfennig A. Epidemiology of bipolar disorders. Epilepsia 46(4): 8-13 (2005).
64. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 73(1/2): 123-31 (2003).
65. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med 2(5): e141 (2005).
66. Phung TK, Andersen BB, Hogh P, Kessing LV, Mortensen PB, Waldemar G. Validity of dementia diagnoses in the Danish hospital registers. Dement Geriatr Cogn Disord 24(3): 220-8 (2007).
67. Henderson T, Shepheard J, Sundararajan V. Quality of diagnosis and procedure coding in ICD-10 administrative data. Med Care 44(11): 1011-9 (2006).